Loading...

Connecting Cancer Research and practice in western Sydney Building research capacity and excellence Developing Multidisciplinary Teams as translational research units

Home

Make an enquiry

Creating a connected professional community of cancer research and practice in western Sydney

The Sydney West Translational Cancer Research Centre (SWTCRC) is one of seven Cancer Institute NSW funded Translational Cancer Research Centres incorporating research, clinical training, education and service delivery within a formal framework that links leading research and clinical centres.

SWTCRC devotes itself to removing barriers, supporting and amplifying the skills and achievements of our workforce enabling them to provide ever greater benefits to our community.

Our Flagship Programs

Events

9
Sep

Sydney Cancer Conference 2021. Bridging Research and Practice

09/09/2021 - 10/09/2021

Become a member

Dear SWTCRC members,

It is with a mixture of sadness and pride that we said farewell to the Sydney West TCRC yesterday on June 30, 2021. Our TCRC changed the world of oncology in the west of Sydney. Our MDTs have blossomed, matured, and continue to transform the way we care for our patients. The glistening new aspect of our MDTs is their role in recognising important clinical questions at the coal face, and presenting these to the research community to help solve. Watch for some exciting announcements in the next few months about how we will add further research firepower to our MDTs to enrich the environment in which we work, and improve outcomes.
Picture: Cancer Council NSW
Professor Jacob George AM, SWTCRC Flagship Leader and Executive Committee member has been named as the 2021 recipient of the Sally Crossing Award which recognises outstanding achievement in cancer research, particularly research that includes consumer involvement. The HOTTeR West (Liver Wellness) Flagship program addresses the rising incidence of hepatocellular cancer (HCC) due to increasing prevalence of chronic viral hepatitis in Australia. The program aims to support patients and health professionals manage chronic disease that contributes to increased risk of HCC.